Reichman University
Herzliya, Israel
Dr. Gilad Halpert is a trained biologist/immunologist with expertise in: experimental inflammatory/autoimmune diseases, improved drug delivery for the treatment of inflammatory/autoimmune diseases, functional autoantibodies and dangerous adjuvants affecting the immune system. Dr. Halpert holds B.Sc degree in Biology and M.Sc. and Ph.D. degrees in Biotechnology from Bar Ilan University, Israel – where he found a beneficial effect of novel Tellurium-based immunomodulators compounds for the treatment of experimental inflammatory bowel diseases (IBD). Dr. Halpert continued to his postdoctoral studies at The Center for Nanomedicine, Johns Hopkins University, School of Medicine, USA – where he gained expertise in 'Nanomedicine-based therapeutic delivery for the treatment of IBD'. Currently, Dr. Halpert is the research manager of a research laboratory at The Center for Autoimmune Diseases, Sheba Medical Center, Israel – where he conducts innovative research strategies for improving the management of inflammatory/autoimmune and rheumatic diseases (such as: IBD, RA, Fibromyalgia syndrome, silicone breast illness etc.) and supervise medical sciences and medical students. Dr. Halpert also serves as Senior Lecturer at the Dina Recanati, Faculty of Medicine, at Reichman University, Israel.
Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
1332: Mid‐Infrared Spectroscopy for Enhanced Diagnosis of Rheumatic Diseases
Monday, October 27, 2025
10:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose
